IL17A and breast cancer: Coffelt et al. confirmed in a breast cancer model that IL-17 might induce tumor immunosuppression and promote tumor neovascularization, among which, Il-17 inhibits the activity of CD8+T cells by regulating the tumor-infiltrating neutrophils (Coffelt et al., 2015).